The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study

• Published in: European radiology Vol. 28; no. 3; pp. 1215 - 1226
• Main Authors: Martens, Roland M., Bechten, Arianne, Ingala, Silvia, van Schijndel, Ronald A., Machado, Vania B., de Jong, Marcus C., Sanchez, Esther, Purcell, Derk, Arrighi, Michael H., Brashear, Robert H., Wattjes, Mike P., Barkhof, Frederik
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2018; Springer Nature B.V
• Subjects: Abnormalities; Aged; Alzheimer Disease - complications; Alzheimer Disease - diagnosis; Alzheimer Disease - drug therapy; Alzheimer's disease; Amyloid; Amyloidosis - complications; Amyloidosis - diagnosis; Amyloidosis - drug therapy; Antibodies, Monoclonal, Humanized - administration & dosage; Brain; Brain - diagnostic imaging; Brain Edema - diagnosis; Brain Edema - drug therapy; Brain Edema - etiology; Classification; Clinical trials; Correlation coefficient; Correlation coefficients; Diagnostic Radiology; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Effusion; Female; Follow-Up Studies; Humans; Image detection; Imaging; Immunotherapy; Injections, Intravenous; Internal Medicine; Interventional Radiology; Magnetic resonance imaging; Magnetic Resonance Imaging - methods; Male; Measurement methods; Medical research; Medical treatment; Medicine; Medicine & Public Health; Neuro; Neurodegenerative diseases; Neuroimaging; Neuroradiology; Patients; Radiology; Reproducibility of Results; ROC Curve; Senile plaques; Sensitivity; Sensitivity analysis; Statistical methods; Swelling; Ultrasound; Alzheimer's disease (AD); MRI (magnetic resonance imaging); ARIA (amyloid-related imaging abnormalities); Immunotherapy; Amyloid beta (Aβ)
• ISSN: 0938-7994; 1432-1084
• DOI: 10.1007/s00330-017-5022-6

Background Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials. Purpose To investigate the applicability of subtraction MRI in the ARIA-E detection using an established ARIA-E-rating scale. Methods We included 75 AD patients receiving bapineuzumab treatment, including 29 ARIA-E cases. Five neuroradiologists rated their brain MRI-scans with and without subtraction images. The accuracy of evaluating the presence of ARIA-E, intraclass correlation coefficient (ICC) and specific agreement was calculated. Results Subtraction resulted in higher sensitivity (0.966) and lower specificity (0.970) than native images (0.959, 0.991, respectively). Individual rater detection was excellent. ICC scores ranged from excellent to good, except for gyral swelling (moderate). Excellent negative and good positive specific agreement among all ARIA-E imaging features was reported in both groups. Combining sulcal hyperintensity and gyral swelling significantly increased positive agreement for subtraction images. Conclusion Subtraction MRI has potential as a visual aid increasing the sensitivity of ARIA-E assessment. However, in order to improve its usefulness isotropic acquisition and enhanced training are required. The ARIA-E rating scale may benefit from combining sulcal hyperintensity and swelling. Key Points • Subtraction technique can improve detection amyloid-related imaging-abnormalities with edema/effusion in Alzheimer’s patients. • The value of ARIA-E detection, classification and monitoring using subtraction was assessed. • Validation of an established ARIA-E rating scale, recommendations for improvement are reported. • Complementary statistical methods were employed to measure accuracy, inter-rater-reliability and specific agreement.